For: | Li M, Kaili D, Shi L. Biomarkers for response to immune checkpoint inhibitors in gastrointestinal cancers. World J Gastrointest Oncol 2022; 14(1): 19-37 [PMID: 35116101 DOI: 10.4251/wjgo.v14.i1.19] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v14/i1/19.htm |
Number | Citing Articles |
1 |
Cheng-Lun Lai, Ming-Huang Chen. Durable Response of Immune Checkpoint Inhibitor for a Patient with Advanced Gastric Adenosquamous Carcinoma. Journal of Cancer Research and Practice 2022; 9(4): 145 doi: 10.4103/2311-3006.362634
|
2 |
A. B. Rays, М. Yu. Fedyanin, D. V. Popov, I. А. Pokataev, М. A. Lyadova, L. G. Zhukova, D. L. Stroyakovsky, М. V. Volkonsky, D. А. Gavrilova, N. S. Besova, А. А. Tryakin. Efficacy of immunotherapy in advanced gastric cancer: preliminary results of a multicenter observational study. Malignant tumours 2024; 14(2): 9 doi: 10.18027/2224-5057-2024-006
|
3 |
Yoshiaki Shoji, Kazuo Koyanagi, Kohei Kanamori, Kohei Tajima, Mika Ogimi, Yamato Ninomiya, Miho Yamamoto, Akihito Kazuno, Kazuhito Nabeshima, Takayuki Nishi, Masaki Mori. Immunotherapy for esophageal cancer: Where are we now and where can we go. World Journal of Gastroenterology 2024; 30(19): 2496-2501 doi: 10.3748/wjg.v30.i19.2496
|
4 |
Serene El Fil, Olivier Uwishema, Aisha Rizwan Ahmed, Tanya Ratnani, Ameen Rupani, Sarah Mshaymesh. Immunotherapy in gastrointestinal cancers: current strategies and future directions – a literature review. Annals of Medicine & Surgery 2025; 87(1): 151 doi: 10.1097/MS9.0000000000002757
|
5 |
Wan‐Yuan Ruan, Lu Zhang, Shan Lei, Zhi‐Rui Zeng, Yu‐Shi Yang, Wen‐Peng Cao, Qiu‐Yao Hao, Min Lu, Xiao‐Bin Tian, Pai‐Lan Peng. An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2023; 27(13): 1820 doi: 10.1111/jcmm.17780
|